Ajinomoto to acquire Forge Biologics for $620m to enhance genetic medicine capabilities

Ajinomoto Co., Inc., a prominent player in the biotechnology industry, has entered into a definitive agreement to acquire Forge Biologics, a leading genetic medicines manufacturer, ... Read More